These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11708917)

  • 1. Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis.
    Soper DL; Milbank JB; Mieling GE; Dirr MJ; Kende AS; Cooper R; Jee WS; Yao W; Chen JL; Bodman M; Lundy MW; De B; Stella ME; Ebetino FH; Wang Y; deLong MA; Wos JA
    J Med Chem; 2001 Nov; 44(24):4157-69. PubMed ID: 11708917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
    Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
    Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of 13,14-dihydro prostaglandin F(1alpha) analogues as potent and selective ligands for the human FP receptor.
    Wang Y; Wos JA; Dirr MJ; Soper DL; deLong MA; Mieling GE; De B; Amburgey JS; Suchanek EG; Taylor CJ
    J Med Chem; 2000 Mar; 43(5):945-52. PubMed ID: 10715159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design and synthesis of selective prostaglandin analogs as bone anabolic agents for the potential treatment of osteoporosis.
    Soper DL; Wang Y; De B; deLong MA; Dirr MJ; Soehner ME; Lundy MW; Mieling GE; Wos JA
    Adv Exp Med Biol; 2002; 507():303-7. PubMed ID: 12664601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
    Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis and human FP receptor binding affinity of 13,14-dihydro prostaglandin F1alpha sulfonamides: potential treatments for osteoporosis.
    Wang Y; Soper DL; Dirr MJ; deLong MA; De B; Wos JA
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1332-7. PubMed ID: 10993232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acylated glucosamines for bone and joint disorders: effects of N-butyryl glucosamine on ovariectomized rat bone.
    Anastassiades T; Rees-Milton K; Xiao H; Yang X; Willett T; Grynpas M
    Transl Res; 2013 Aug; 162(2):93-101. PubMed ID: 23680489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic modification of prostaglandin f(2alpha) indicates different structural determinants for binding to the prostaglandin F receptor versus the prostaglandin transporter.
    Schuster VL; Itoh S; Andrews SW; Burk RM; Chen J; Kedzie KM; Gil DW; Woodward DF
    Mol Pharmacol; 2000 Dec; 58(6):1511-6. PubMed ID: 11093791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dried plum reverses bone loss in an osteopenic rat model of osteoporosis.
    Deyhim F; Stoecker BJ; Brusewitz GH; Devareddy L; Arjmandi BH
    Menopause; 2005; 12(6):755-62. PubMed ID: 16278620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiosteoporotic activity of echinacoside in ovariectomized rats.
    Li F; Yang X; Yang Y; Guo C; Zhang C; Yang Z; Li P
    Phytomedicine; 2013 Apr; 20(6):549-57. PubMed ID: 23428402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteolytic potency of 16-phenoxy-derivatives of prostaglandin F2 alpha.
    Brambaifa N
    Experientia; 1988 Jan; 44(1):45-7. PubMed ID: 3162421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intermittent and daily regimens of minodronic Acid on bone metabolism in an ovariectomized rat model of osteoporosis.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Yamada H; Kawada N; Kawabata K
    Calcif Tissue Int; 2014 Aug; 95(2):166-73. PubMed ID: 24903232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
    Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
    J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor.
    Sharif NA; Davis TL; Williams GW
    J Pharm Pharmacol; 1999 Jun; 51(6):685-94. PubMed ID: 10454045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
    Ma YF; Pan Z; Jee WS; Lin CH; Liang HH; Chen H; Pun S; Li XJ
    J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
    Sharif NA; Kelly CR; Crider JY
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AL-3138 antagonizes FP prostanoid receptor-mediated inositol phosphates generation: comparison with some purported FP antagonists.
    Sharif NA; Crider JY; Davis TL
    J Pharm Pharmacol; 2000 Dec; 52(12):1529-39. PubMed ID: 11197083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.
    Sharif NA; Klimko PG
    Br J Pharmacol; 2019 Apr; 176(8):1059-1078. PubMed ID: 29679483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.